Preventive Value of Aflibercept Questioned in NPDR Without CI-DME
Anatomic improvement, but no improvement in visual acuity, reported with aflibercept given for four years versus sham
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.